Aptevo Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aptevo Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2024.
  • Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$6.31M, a 6.95% decline year-over-year.
  • Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$24.1M, a 38.6% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$24.1M, a 38.6% decline from 2023.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$17.4M, a 317% decline from 2022.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $8.03M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$24.1M -$6.72M -38.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 -$17.4M -$25.4M -317% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $8.03M +$36.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$28.5M -$10.7M -60.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$17.8M +$22.7M +56.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$40.4M +$13.2M +24.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$53.7M -$60.7M -870% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $6.97M +$119M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$112M -$53.1M -89.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 -$59.3M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.